A physiologically based pharmacokinetic model for 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice
- 1 July 1988
- journal article
- research article
- Published by Elsevier in Toxicology Letters
- Vol. 42 (1) , 15-28
- https://doi.org/10.1016/0378-4274(88)90098-7
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The toxicological significance of 2, 3, 7, 8‐tetrachlorodibenzo‐p‐dioxin and related compounds in human adipose tissueJournal of Toxicology and Environmental Health, 1987
- Metabolism and disposition of 2,3,7,8-tetrachlorodibenzo-p-dioxin in guinea pigsToxicology and Applied Pharmacology, 1986
- DioxinScientific American, 1986
- Pharmacokinetics of 2,3,7,8-TCDD in manChemosphere, 1986
- The Toxicokinetics of 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin in Mammalian SystemsDrug Metabolism Reviews, 1982
- Tissue distribution, excretion, and metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the Golden Syrian hamsterToxicology and Applied Pharmacology, 1980
- 2,3,7,8-Tetrachlorodibenzo-p-dioxin tissue distribution, excretion, and effects on clinical chemical parameters in guinea pigsToxicology and Applied Pharmacology, 1979
- A review of the applications of physiologically based pharmacokinetic modelingJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the immune system of laboratory animals.Environmental Health Perspectives, 1973
- Genetic Regulation of Aryl Hydrocarbon Hydroxylase InductionPublished by Elsevier ,1972